KLK3 Gene - CISMeF

Preferred Label : KLK3 Gene;

NCIt synonyms : Kallikrein 3, (Prostate Specific Antigen) Gene; PSA;

NCIt related terms : KLK3;

CISMeF acronym : KLK3;

NCIt definition : This gene is involved in the hydrolysis of high molecular mass seminal vesicle protein, resulting in the liquefaction of seminal coagulum.;

Détails

Origin ID

C26585;

UMLS CUI

C1366489;

HGNC gene
- kallikrein related peptidase 3 [HGNC gene]
OMIM relation
- Kallikrein-related peptidase 3 [OMIM gene]
Semantic type(s)
- Gene or Genome [UMLS semantic type]
UMLS correspondences (same concept)
- Kallikrein-related peptidase 3 [OMIM gene]
- kallikrein related peptidase 3 [HGNC gene]
concept_is_in_subset
- CTRP Biomarker Terminology [NCIt concept]
- CTRP Molecular Genetic Biomarker Terminology [NCIt concept]
- CTRP Reference Gene Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
gene_encodes_gene_product
- Prostate-Specific Antigen [NCIt concept]
gene_found_in_organism
- Human [NCIt concept]
gene_is_biomarker_of
- Prostate Carcinoma [NCIt concept]
gene_plays_role_in_process
- Hydrolysis [NCIt concept]
- Proteolysis [NCIt concept]
genetic_biomarker_related_to
- 4Kscore [NCIt concept]
- Age-Adjusted PSA [NCIt concept]
- Free PSA to Total PSA Ratio Measurement [NCIt concept]
- Free Prostate Specific Antigen Measurement [NCIt concept]
- Most Recent PSA Level Question [NCIt concept]
- PCA3 Score Greater than 35 [NCIt concept]
- PCA3 mRNA to PSA mRNA Ratio Measurement [NCIt concept]
- PSA 50 Percent or Greater than Nadir [NCIt concept]
- PSA Antibody [NCIt concept]
- PSA Bounce [NCIt concept]
- PSA Decline Greater than 30 Percent [NCIt concept]
- PSA Decline Greater than 50 Percent [NCIt concept]
- PSA Decline Greater than 75 Percent [NCIt concept]
- PSA Decline Greater than 90 Percent [NCIt concept]
- PSA Decline Greater than or Equal to 25 Percent [NCIt concept]
- PSA Decline Greater than or Equal to 30 Percent [NCIt concept]
- PSA Decline Greater than or Equal to 50 Percent [NCIt concept]
- PSA Decline Greater than or Equal to 90 Percent [NCIt concept]
- PSA Density Less than 0.15 [NCIt concept]
- PSA Density Less than 0.2 [NCIt concept]
- PSA Density Less than 0.3 [NCIt concept]
- PSA Doubling Time [NCIt concept]
- PSA Doubling Time Greater than 3 Months [NCIt concept]
- PSA Doubling Time Greater than 6 Months [NCIt concept]
- PSA Doubling Time Greater than or Equal to 10 Months [NCIt concept]
- PSA Doubling Time Greater than or Equal to 4 Months [NCIt concept]
- PSA Doubling Time Less than 12 Months [NCIt concept]
- PSA Doubling Time Less than 15 Months [NCIt concept]
- PSA Doubling Time Less than or Equal to 10 Months [NCIt concept]
- PSA Doubling Time Less than or Equal to 12 Months [NCIt concept]
- PSA Doubling Time Less than or Equal to 6 Months [NCIt concept]
- PSA Failure [NCIt concept]
- PSA Level [NCIt concept]
- PSA Level 0.05 to 0.7 [NCIt concept]
- PSA Level 0.1 to 0.7 [NCIt concept]
- PSA Level 0.1 to Fifty [NCIt concept]
- PSA Level 0.2 to Fifty [NCIt concept]
- PSA Level 0.2 to Four [NCIt concept]
- PSA Level 0.2 to Ten [NCIt concept]
- PSA Level 0.2 to Two [NCIt concept]
- PSA Level 0.5 to Fifty [NCIt concept]
- PSA Level 0.5 to Ten [NCIt concept]
- PSA Level Equal to Nadir Plus 2 ng/mL [NCIt concept]
- PSA Level Finding [NCIt concept]
- PSA Level Five to Ten [NCIt concept]
- PSA Level Four to Ten [NCIt concept]
- PSA Level Greater than 0 but Less than 0.2 [NCIt concept]
- PSA Level Greater than 0.03 [NCIt concept]
- PSA Level Greater than 0.1 [NCIt concept]
- PSA Level Greater than 0.15 [NCIt concept]
- PSA Level Greater than 0.2 [NCIt concept]
- PSA Level Greater than 0.3 [NCIt concept]
- PSA Level Greater than 0.4 [NCIt concept]
- PSA Level Greater than 0.5 [NCIt concept]
- PSA Level Greater than 2.5 [NCIt concept]
- PSA Level Greater than Fifteen [NCIt concept]
- PSA Level Greater than Fifty [NCIt concept]
- PSA Level Greater than Five [NCIt concept]
- PSA Level Greater than Four [NCIt concept]
- PSA Level Greater than One [NCIt concept]
- PSA Level Greater than One Hundred [NCIt concept]
- PSA Level Greater than One Hundred Fifty [NCIt concept]
- PSA Level Greater than Ten [NCIt concept]
- PSA Level Greater than Twenty [NCIt concept]
- PSA Level Greater than Two [NCIt concept]
- PSA Level Greater than Zero [NCIt concept]
- PSA Level Greater than or Equal to 0.01 [NCIt concept]
- PSA Level Greater than or Equal to 0.05 [NCIt concept]
- PSA Level Greater than or Equal to 0.1 [NCIt concept]
- PSA Level Greater than or Equal to 0.2 [NCIt concept]
- PSA Level Greater than or Equal to 0.4 [NCIt concept]
- PSA Level Greater than or Equal to 0.5 [NCIt concept]
- PSA Level Greater than or Equal to 0.7 [NCIt concept]
- PSA Level Greater than or Equal to 0.8 [NCIt concept]
- PSA Level Greater than or Equal to Eight [NCIt concept]
- PSA Level Greater than or Equal to Fifteen [NCIt concept]
- PSA Level Greater than or Equal to Fifty [NCIt concept]
- PSA Level Greater than or Equal to Five [NCIt concept]
- PSA Level Greater than or Equal to Forty [NCIt concept]
- PSA Level Greater than or Equal to Four [NCIt concept]
- PSA Level Greater than or Equal to One [NCIt concept]
- PSA Level Greater than or Equal to Ten [NCIt concept]
- PSA Level Greater than or Equal to Three [NCIt concept]
- PSA Level Greater than or Equal to Twenty [NCIt concept]
- PSA Level Greater than or Equal to Twenty-Five [NCIt concept]
- PSA Level Greater than or Equal to Two [NCIt concept]
- PSA Level Less than 0.01 [NCIt concept]
- PSA Level Less than 0.02 [NCIt concept]
- PSA Level Less than 0.1 [NCIt concept]
- PSA Level Less than 0.2 [NCIt concept]
- PSA Level Less than 0.4 [NCIt concept]
- PSA Level Less than 0.5 [NCIt concept]
- PSA Level Less than 0.7 [NCIt concept]
- PSA Level Less than Fifteen [NCIt concept]
- PSA Level Less than Fifty [NCIt concept]
- PSA Level Less than Five [NCIt concept]
- PSA Level Less than Forty [NCIt concept]
- PSA Level Less than Four [NCIt concept]
- PSA Level Less than One [NCIt concept]
- PSA Level Less than One Hundred [NCIt concept]
- PSA Level Less than One Hundred Fifty [NCIt concept]
- PSA Level Less than Ten [NCIt concept]
- PSA Level Less than Thirty [NCIt concept]
- PSA Level Less than Twenty [NCIt concept]
- PSA Level Less than Twenty Five [NCIt concept]
- PSA Level Less than Two [NCIt concept]
- PSA Level Less than or Equal to 0.2 [NCIt concept]
- PSA Level Less than or Equal to 0.5 [NCIt concept]
- PSA Level Less than or Equal to Eighty [NCIt concept]
- PSA Level Less than or Equal to Eleven [NCIt concept]
- PSA Level Less than or Equal to Fifteen [NCIt concept]
- PSA Level Less than or Equal to Fifty [NCIt concept]
- PSA Level Less than or Equal to Five [NCIt concept]
- PSA Level Less than or Equal to Four [NCIt concept]
- PSA Level Less than or Equal to One Hundred [NCIt concept]
- PSA Level Less than or Equal to One Hundred Fifty [NCIt concept]
- PSA Level Less than or Equal to Ten [NCIt concept]
- PSA Level Less than or Equal to Thirty [NCIt concept]
- PSA Level Less than or Equal to Twenty [NCIt concept]
- PSA Level Less than or Equal to Two [NCIt concept]
- PSA Level Ten to Fifteen [NCIt concept]
- PSA Level Ten to Fifty [NCIt concept]
- PSA Level Ten to Twenty [NCIt concept]
- PSA Level Twenty to One Hundred Fifty [NCIt concept]
- PSA Level Twenty to One Hundred Fifty or Greater [NCIt concept]
- PSA Level Two to Forty [NCIt concept]
- PSA Level Two to Ten [NCIt concept]
- PSA Level Zero to Forty Four [NCIt concept]
- PSA Level Zero to Two [NCIt concept]
- PSA Nadir Greater than or Equal to 0.5 ng/mL [NCIt concept]
- PSA Nadir Less than 0.2 ng/mL [NCIt concept]
- PSA Nadir Less than 0.5 ng/mL [NCIt concept]
- PSA Nadir Less than or Equal to 0.2 ng/mL [NCIt concept]
- PSA Progression [NCIt concept]
- PSA Velocity [NCIt concept]
- Percent Free Prostate-Specific Antigen [NCIt concept]
- Percent Free Prostate-Specific Antigen Less than 25 [NCIt concept]
- Prostate Health Index [NCIt concept]
- Prostate Specific Antigen Density [NCIt concept]
- Prostate Specific Antigen Measurement [NCIt concept]
- Prostate Specific Antigen mRNA Measurement [NCIt concept]
- Prostate-Specific Antigen [Mass/Volume] in Body Fluid [NCIt concept]
- Prostate-Specific Antigen [Mass/Volume] in Cerebral Spinal Fluid [NCIt concept]
- Prostate-Specific Antigen [Mass/Volume] in Peritoneal Fluid [NCIt concept]
- Prostate-Specific Antigen [Mass/Volume] in Pleural Fluid [NCIt concept]
- Prostate-Specific Antigen [Mass/Volume] in Semen [NCIt concept]
- Prostate-Specific Antigen [Mass/Volume] in Serum or Plasma [NCIt concept]
- Prostate-Specific Antigen [Mass/Volume] in Serum or Plasma by Detection Limit Less than or Equal to 0.01 ng/ml [NCIt concept]
- Prostate-Specific Antigen [Mass/Volume] in Serum or Plasma by Immunoassay [NCIt concept]
- Prostate-Specific Antigen [Mass/Volume] in Urine [NCIt concept]
- Prostate-Specific Antigen [Moles/Volume] in Semen [NCIt concept]
- Prostate-Specific Antigen [Moles/Volume] in Serum or Plasma [NCIt concept]
- Prostate-Specific Antigen [Presence] in Tissue by Immune Stain [NCIt concept]
- Prostate-Specific Antigen [Units/Volume] in Semen [NCIt concept]
- Prostate-Specific Antigen [Units/Volume] in Serum or Plasma [NCIt concept]
- Serum Prostate Specific Antigen Increased [NCIt concept]
- Total PSA [NCIt concept]
- Transition Zone PSA Density [NCIt concept]
- Undetectable PSA [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients